טוען...
Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2
Hereditary angioedema (HAE) is a rare disease that causes episodic attacks of subcutaneous and submucosal edema, which can be painful, incapacitating, and potentially fatal. These attacks are mediated by excessive bradykinin production, as a result of uncontrolled activation of the plasma kallikrein...
שמור ב:
| הוצא לאור ב: | Clin Rev Allergy Immunol |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer US
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8282552/ https://ncbi.nlm.nih.gov/pubmed/33423210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12016-021-08832-x |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|